Cite
A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics.
MLA
Geenen, Joost W., et al. “A Novel Method for Predicting the Budget Impact of Innovative Medicines: Validation Study for Oncolytics.” European Journal of Health Economics, vol. 21, no. 6, Aug. 2020, pp. 845–53. EBSCOhost, https://doi.org/10.1007/s10198-020-01176-x.
APA
Geenen, J. W., Belitser, S. V., Vreman, R. A., van Bloois, M., Klungel, O. H., Boersma, C., & Hövels, A. M. (2020). A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics. European Journal of Health Economics, 21(6), 845–853. https://doi.org/10.1007/s10198-020-01176-x
Chicago
Geenen, Joost W., Svetlana V. Belitser, Rick A. Vreman, Martijn van Bloois, Olaf H. Klungel, Cornelis Boersma, and Anke M. Hövels. 2020. “A Novel Method for Predicting the Budget Impact of Innovative Medicines: Validation Study for Oncolytics.” European Journal of Health Economics 21 (6): 845–53. doi:10.1007/s10198-020-01176-x.